{"id":93379,"date":"2021-03-26T06:47:02","date_gmt":"2021-03-26T06:47:02","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=93379"},"modified":"2022-03-14T05:10:28","modified_gmt":"2022-03-14T05:10:28","slug":"methaemoglobinaemia","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/methaemoglobinaemia\/","title":{"rendered":"Methaemoglobinaemia"},"content":{"rendered":"<p>The presence of methaemoglobin in the blood.<\/p>\n<hr \/>\n<p>A condition due to the presence in the blood of methaemoglobin. It is characterized by cyanosis which turns the skin and lips a blue colour, shortness of breath, headache, fatigue and sickness. There are two main forms: a hereditary form and a toxic form. The latter can be caused by certain drugs, including acetanilide, phenacetin, the sulphonamides and benzocaine. The treatment of the toxic form is the withdrawal of the causative drug. In the more severe cases the administration of methylene blue or ascorbic acid may also be needed; these are the drugs used in the hereditary form.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The presence of methaemoglobin in the blood. A condition due to the presence in the blood of methaemoglobin. It is characterized by cyanosis which turns the skin and lips a blue colour, shortness of breath, headache, fatigue and sickness. There are two main forms: a hereditary form and a toxic form. The latter can be [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-93379","post","type-post","status-publish","format-standard","hentry","category-m"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Methaemoglobinaemia - Definition of Methaemoglobinaemia<\/title>\n<meta name=\"description\" content=\"The presence of methaemoglobin in the blood.A condition due to the presence in the blood of methaemoglobin. It is characterized by cyanosis which turns the skin and lips a blue colour, shortness of breath, headache, fatigue and sickness. There are two main forms: a hereditary form and a toxic form. The latter can be caused by certain drugs, including acetanilide, phenacetin, the sulphonamides and benzocaine. The treatment of the toxic form is the withdrawal of the causative drug. In the more severe cases the administration of methylene blue or ascorbic acid may also be needed; these are the drugs used in the hereditary form.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/methaemoglobinaemia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Methaemoglobinaemia - Definition of Methaemoglobinaemia\" \/>\n<meta property=\"og:description\" content=\"The presence of methaemoglobin in the blood.A condition due to the presence in the blood of methaemoglobin. It is characterized by cyanosis which turns the skin and lips a blue colour, shortness of breath, headache, fatigue and sickness. There are two main forms: a hereditary form and a toxic form. The latter can be caused by certain drugs, including acetanilide, phenacetin, the sulphonamides and benzocaine. The treatment of the toxic form is the withdrawal of the causative drug. In the more severe cases the administration of methylene blue or ascorbic acid may also be needed; these are the drugs used in the hereditary form.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/methaemoglobinaemia\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-26T06:47:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-14T05:10:28+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/methaemoglobinaemia\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/methaemoglobinaemia\/\",\"name\":\"Methaemoglobinaemia - Definition of Methaemoglobinaemia\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-03-26T06:47:02+00:00\",\"dateModified\":\"2022-03-14T05:10:28+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"The presence of methaemoglobin in the blood.A condition due to the presence in the blood of methaemoglobin. It is characterized by cyanosis which turns the skin and lips a blue colour, shortness of breath, headache, fatigue and sickness. There are two main forms: a hereditary form and a toxic form. The latter can be caused by certain drugs, including acetanilide, phenacetin, the sulphonamides and benzocaine. The treatment of the toxic form is the withdrawal of the causative drug. In the more severe cases the administration of methylene blue or ascorbic acid may also be needed; these are the drugs used in the hereditary form.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/methaemoglobinaemia\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/methaemoglobinaemia\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/methaemoglobinaemia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Methaemoglobinaemia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Methaemoglobinaemia - Definition of Methaemoglobinaemia","description":"The presence of methaemoglobin in the blood.A condition due to the presence in the blood of methaemoglobin. It is characterized by cyanosis which turns the skin and lips a blue colour, shortness of breath, headache, fatigue and sickness. There are two main forms: a hereditary form and a toxic form. The latter can be caused by certain drugs, including acetanilide, phenacetin, the sulphonamides and benzocaine. The treatment of the toxic form is the withdrawal of the causative drug. In the more severe cases the administration of methylene blue or ascorbic acid may also be needed; these are the drugs used in the hereditary form.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/methaemoglobinaemia\/","og_locale":"en_US","og_type":"article","og_title":"Methaemoglobinaemia - Definition of Methaemoglobinaemia","og_description":"The presence of methaemoglobin in the blood.A condition due to the presence in the blood of methaemoglobin. It is characterized by cyanosis which turns the skin and lips a blue colour, shortness of breath, headache, fatigue and sickness. There are two main forms: a hereditary form and a toxic form. The latter can be caused by certain drugs, including acetanilide, phenacetin, the sulphonamides and benzocaine. The treatment of the toxic form is the withdrawal of the causative drug. In the more severe cases the administration of methylene blue or ascorbic acid may also be needed; these are the drugs used in the hereditary form.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/methaemoglobinaemia\/","og_site_name":"Glossary","article_published_time":"2021-03-26T06:47:02+00:00","article_modified_time":"2022-03-14T05:10:28+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/methaemoglobinaemia\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/methaemoglobinaemia\/","name":"Methaemoglobinaemia - Definition of Methaemoglobinaemia","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-03-26T06:47:02+00:00","dateModified":"2022-03-14T05:10:28+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"The presence of methaemoglobin in the blood.A condition due to the presence in the blood of methaemoglobin. It is characterized by cyanosis which turns the skin and lips a blue colour, shortness of breath, headache, fatigue and sickness. There are two main forms: a hereditary form and a toxic form. The latter can be caused by certain drugs, including acetanilide, phenacetin, the sulphonamides and benzocaine. The treatment of the toxic form is the withdrawal of the causative drug. In the more severe cases the administration of methylene blue or ascorbic acid may also be needed; these are the drugs used in the hereditary form.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/methaemoglobinaemia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/methaemoglobinaemia\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/methaemoglobinaemia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Methaemoglobinaemia"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/93379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=93379"}],"version-history":[{"count":3,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/93379\/revisions"}],"predecessor-version":[{"id":148928,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/93379\/revisions\/148928"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=93379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=93379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=93379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}